532154 — Johnson Pharmacare Income Statement
0.000.00%
Last trade - 00:00- IN₹286.00m
- IN₹499.22m
Annual income statement for Johnson Pharmacare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 32.6 | 25.3 | 0 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 5.71 | 5.05 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 31.3 | 23 | 1.96 | 2.5 | 555 |
| Operating Profit | 1.34 | 2.23 | -1.96 | -2.5 | -555 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1.34 | -13.3 | -1.96 | -5.84 | -557 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.967 | -12.9 | -1.96 | -5.84 | -557 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.967 | -12.9 | -1.96 | -5.84 | -557 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.967 | -12.9 | -1.96 | -5.84 | -557 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.002 | -0.023 | -0.004 | -0.011 | -0.751 |